Atlas Trials

An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

Clinical trial NCT00685204 · UNKNOWN

Trial details

NCT number
NCT00685204
Sponsor
Taxolog Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Mesothelioma
Start date
2008-03-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.